Zobrazeno 1 - 10
of 140
pro vyhledávání: '"PO Livingston"'
Publikováno v:
Journal of Lipid Research, Vol 34, Iss 9, Pp 1565-1572 (1993)
We previously reported a hamster animal model of melanoma in which the tumor tissue expresses gangliosides GM3, GD3, and O-acetyl GD3. This ganglioside pattern is similar to that in human melanomas (Ren, S., A. Slominski, and R. K. Yu. 1989 Cancer Re
Externí odkaz:
https://doaj.org/article/ccb67ac373824703b24a39f9d0b153a5
Autor:
Rosenbaum E; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical Center, New York, NY, USA., Chugh R; University of Michigan, Ann Arbor, MI, USA., Ryan CW; Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA., Agulnik M; City of Hope, Duarte, CA, USA., Milhem MM; University of Iowa and Clinic Holden Cancer Center, Iowa City, IA, USA., George S; Dana-Farber Cancer Institute, Boston, MA, USA., Jones RL; Royal Marsden/Institute of Cancer Research, London, GB. Previous Affiliation: University of Washington/ Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Chmielowski B; Jonsson Comprehensive Cancer Center, University of California Los Angeles, Los Angeles, CA, USA., Van Tine BA; Washington University in Saint Louis, Saint Louis, MO, USA., Tawbi H; University of Texas MD Anderson Cancer Center, Houston, TX, USA., Elias AD; University of Colorado Cancer Center, Aurora, CO, USA., Read WL; Emory University, Atlanta, GA, USA., Budd GT; Cleveland Clinic, Cleveland, OH, USA., Qin LX; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Rodler ET; UC Davis Comprehensive Cancer Center, Los Angeles, CA, USA., Hirman J; Pacific Northwest Statistical Consulting, Inc, USA., Weiden P; BioPharma Consulting Services, LLC, USA., Bennett CM; BioPharma Consulting Services, LLC, USA., Livingston PO; MabVax Therapeutics, Inc., USA., Ragupathi G; Memorial Sloan-Kettering Cancer Center, New York, NY, USA., Hansen D; MabVax Therapeutics, Inc., USA., D'Angelo SP; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical Center, New York, NY, USA., Tap WD; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical Center, New York, NY, USA., Schwartz GK; Columbia University Medical Center, New York, NY, USA., Maki RG; Abramson Cancer Center at the University of Pennsylvania, Philadelphia, PA, USA., Carvajal RD; Columbia University Medical Center, New York, NY, USA. Electronic address: carvajalr@columbia.edu.
Publikováno v:
European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2022 Nov; Vol. 176, pp. 155-163. Date of Electronic Publication: 2022 Oct 08.
Autor:
Fernández-Tejada A; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: fernana2@mskcc.org., Chea EK; Pharmacology Graduate Program, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., George C; Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Gardner JR; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Livingston PO; Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Ragupathi G; Melanoma and Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: ragupatg@mskcc.org., Tan DS; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Pharmacology Graduate Program, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA. Electronic address: tand@mskcc.org., Gin DY; Molecular Pharmacology and Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Pharmacology Graduate Program, Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA; Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA.
Publikováno v:
Bioorganic & medicinal chemistry [Bioorg Med Chem] 2014 Nov 01; Vol. 22 (21), pp. 5917-23. Date of Electronic Publication: 2014 Sep 17.
Autor:
Fernández-Tejada A; Molecular Pharmacology & Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Chea EK; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., George C; Melanoma & Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Pillarsetty N; Radiochemistry & Imaging Science Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Gardner JR; Molecular Pharmacology & Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Livingston PO; 1] Melanoma & Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA [2]., Ragupathi G; Melanoma & Immunotherapeutics Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Lewis JS; Radiochemistry & Imaging Science Service, Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Tan DS; 1] Molecular Pharmacology & Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA [2] Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA [3] Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA., Gin DY; 1] Molecular Pharmacology & Chemistry Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA [2] Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA [3] Tri-Institutional Research Program, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York 10065, USA [4].
Publikováno v:
Nature chemistry [Nat Chem] 2014 Jul; Vol. 6 (7), pp. 635-43. Date of Electronic Publication: 2014 Jun 01.
Autor:
Viola-Villegas NT; Program in Molecular Pharmacology and Chemistry, Memorial Sloan-Kettering Cancer Center, New York, New York., Rice SL, Carlin S, Wu X, Evans MJ, Sevak KK, Drobjnak M, Ragupathi G, Sawada R, Scholz WW, Livingston PO, Lewis JS
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2013 Nov; Vol. 54 (11), pp. 1876-82. Date of Electronic Publication: 2013 Sep 12.
Autor:
Wu X; Laboratory of Tumor Vaccinology, Melanoma Sarcoma Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA., Ragupathi G, Panageas K, Hong F, Livingston PO
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Sep 01; Vol. 19 (17), pp. 4728-39. Date of Electronic Publication: 2013 Jul 05.
Autor:
Chea EK; Pharmacology Program, Weill Cornell Graduate School of Medical Sciences, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA., Fernández-Tejada A, Damani P, Adams MM, Gardner JR, Livingston PO, Ragupathi G, Gin DY
Publikováno v:
Journal of the American Chemical Society [J Am Chem Soc] 2012 Aug 15; Vol. 134 (32), pp. 13448-57. Date of Electronic Publication: 2012 Aug 06.
Autor:
Krug LM; Thoracic Oncology Service, Memorial Sloan-Kettering Cancer Center, Weill Medical College of Cornell University, 1275 York Ave., New York, NY 10065, USA. krugl@mskcc.org, Ragupathi G, Hood C, George C, Hong F, Shen R, Abrey L, Jennings HJ, Kris MG, Livingston PO
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2012 Jan; Vol. 61 (1), pp. 9-18. Date of Electronic Publication: 2011 Aug 03.
Autor:
Hong F; Laboratory of Tumor Vaccinology, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, USA., Xiao W, Ragupathi G, Lau CB, Leung PC, Yeung KS, George C, Cassileth B, Kennelly E, Livingston PO
Publikováno v:
Planta medica [Planta Med] 2011 May; Vol. 77 (8), pp. 817-24. Date of Electronic Publication: 2010 Dec 02.
Autor:
Kim SK; Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA., Wu X, Ragupathi G, Gathuru J, Koide F, Cheung NK, Panageas K, Livingston PO
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2011 May; Vol. 60 (5), pp. 621-7. Date of Electronic Publication: 2011 Jan 26.